Mednet Logo
HomeQuestion

When should bone biopsy be considered to guide management in patients in whom you're differentiating osteoporosis and renal osteodystrophy?

1 Answers
Mednet Member
Mednet Member
Nephrology · Indiana University School of Medicine

This is a major issue in patients with advanced CKD. Definitive RCT treatment trials for osteoporosis had an inclusion criteria of a normal PTH and an exclusion criteria of elevated creatinine greater than 1.1 to 1.5 (depending on the study). Therefore, in patients with CKD 3 and more severe CKD, AN...

Register or Sign In to see full answer

When should bone biopsy be considered to guide management in patients in whom you're differentiating osteoporosis and renal osteodystrophy? | Mednet